Eidogen-Sertanty is a San Diego-based company dedicated to delivering pioneering informatics technologies that will drive drug discovery in the post-genomic era. Through the integration of advanced ligand and structure-based informatics techniques, Eidogen-Sertanty's software and solutions effectively bridge the existing knowledge gap between biology and chemistry.

Our major discovery informatics platforms TIP™, ChIP™, Kinase Knowledgebase™, and ARK™ allow our pharmaceutical customer base to leverage public and proprietary chemical and structural knowledge to substantially improve the overall efficiency of the drug discovery cycle from hit to lead, increasing the odds and lowering the costs of successfully developing novel, safe, and effective drug compounds.

Our DirectDesign™ Discovery Service combines all of our proprietary technologies for the directed de novo design of lead compounds and target-focused virtual libraries. Our biotechnology and pharmaceutical clients utilize DirectDesign to fully exploit the complete spectrum of Eidogen-Sertanty's knowledge-driven discovery informatics capabilities on a project-by-project basis.